Earnings calls

Alkem Lab concall ledger

Every earnings call for ALKEM — management tone, guidance, KPIs and promise tracking, quarter by quarter.

ALKEM · 6 transcripts · Healthcare · latest Q4 FY26

Q4 FY26Published 28 May 2026Call held 28 May 2026

ALKEM Q4 FY26 Earnings Call Transcript & Analysis

Revenue36,033 million+15% YoYEBITDA5,174 million+32% YoYEBITDA Margin14.4%Net Profit2,365 millionPBT5,578 million+41% YoY

Revenue (Q4 FY26) 36033 million (+15% YoY); EBITDA (Q4 FY26) 5174 million (+32% YoY); EBITDA Margin (Q4 FY26) 14.4%. FY26 EBITDA crossed INR3,000 crores (INR30,000 million), with a 19.6% Y-o-Y growth.

Read full transcript & analysis

Q3 FY26Published 13 Feb 2026Call held 13 Feb 2026

ALKEM Q3 FY26 Earnings Call Transcript & Analysis

Total Revenue37,368 million+11% YoYEBITDA8,280 million+9% YoYEBITDA Margin22.2%Net Profit6,360 million+2% YoYPBT7,812 million+7% YoY

Total Revenue 37368 million (+11% YoY); EBITDA 8280 million (+9% YoY); EBITDA Margin 22.2%. Total revenue grew 10.7% YoY to INR 37,368 million.

Read full transcript & analysis

Q2 FY26Published 13 Nov 2025Call held 13 Nov 2025

ALKEM Q2 FY26 Earnings Call Transcript & Analysis

Revenue₹4,001 cr+17% YoYEBITDA₹920.8 cr+22% YoYEBITDA Margin23%Net Profit₹765.1 cr+11% YoY

Revenue ₹4,001 cr (+17% YoY); EBITDA ₹921 cr (+22% YoY); EBITDA Margin 23.0%. Total revenue reached an all-time high of INR4001 crores, growing 17.2% YoY.

Read full transcript & analysis

Q1 FY26Published 12 Aug 2025Call held 12 Aug 2025

ALKEM Q1 FY26 Earnings Call Transcript & Analysis

Total Revenue33,711 million+11% YoYEBITDA7,391 million+21% YoYEBITDA Margin21.9%Net Profit6,643 million+22% YoY

Total Revenue 33711 million (+11% YoY); EBITDA 7391 million (+21% YoY); EBITDA Margin 21.9%. Total revenue from operations stood at INR33,711 million with Y-o-Y growth of 11.2%.

Read full transcript & analysis

Q4 FY25Published 29 May 2025Call held 29 May 2025

ALKEM Q4 FY25 Earnings Call Transcript & Analysis

EBITDA₹2,512.2 cr+12% YoYEBITDA Margin19.4%Net Profit₹305.9 cr+4% YoY

EBITDA (FY25) ₹2,512 cr (+12% YoY); EBITDA Margin (FY25) 19.4%; Net Profit (Q4) ₹306 cr (+4% YoY). Total revenue from operations for Q4 FY25 was Rs. 3,143.8 crores, up 7.1% YoY.

Read full transcript & analysis

Q3 FY25Published 07 Feb 2025Call held 07 Feb 2025

ALKEM Q3 FY25 Earnings Call Transcript & Analysis

Revenue from Operations33,743 million+2% YoYEBITDA7,594 million+7% YoYEBITDA Margin22.5%Net Profit6,258 million+5% YoY

Revenue from Operations 33743 million (+2% YoY); EBITDA 7594 million (+7% YoY); EBITDA Margin 22.5%. Revenue from operations for Q3 FY25 was INR33,743 million, with a 1.5% YoY growth.

Read full transcript & analysis